Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Suttorp

Showing results (201-210 of 278) with videos related to

Pageof 28
Sort By:
Scientific Reports|November 29, 2022
Transcriptomic comparison of primary human lung cells with lung tissue samples and the human A549 lung cell line highlights cell type specific responses during infections with influenza A virusWilhelm Bertrams, Katja Hönzke, Benedikt Obermayer, et al.
Translational Lung Cancer Research|March 15, 2021
KRAS<sup>G12C</sup>/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinomaNikolaj Frost, Jens Kollmeier, Claudia Vollbrecht, et al.
Infection|July 9, 2023
Pathogen spectrum of community acquired pneumonia in people living with HIV (PLWH) in the German CAPNETZ-CohortBenjamin T Schleenvoigt, Juliane Ankert, Grit Barten-Neiner, et al.
Respiratory Research|September 10, 2022
Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study groupMathias W Pletz, Andreas Vestergaard Jensen, Christina Bahrs, et al.
Mbio|October 10, 2013
The novel human influenza A(H7N9) virus is naturally adapted to efficient growth in human lung tissueJessica Knepper, Kristina L Schierhorn, Anne Becher, et al.
Critical Care (London, England)|November 15, 2017
Vasculotide reduces pulmonary hyperpermeability in experimental pneumococcal pneumoniaBirgitt Gutbier, Xiaohui Jiang, Kristina Dietert, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 17, 2021
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational studyBarbara Mühlemann, Charlotte Thibeault, David Hillus, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 18, 2022
Initial Experience With SARS-CoV-2-Neutralizing Monoclonal Antibodies in Kidney or Combined Kidney-Pancreas Transplant RecipientsFriederike Bachmann, Klemens Budde, Norbert Suttorp, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2015
CFTR and sphingolipids mediate hypoxic pulmonary vasoconstrictionChristoph Tabeling, Hanpo Yu, Liming Wang, et al.
Plos Pathogens|January 4, 2018
The common HAQ STING variant impairs cGAS-dependent antibacterial responses and is associated with susceptibility to Legionnaires' disease in humansJuan S Ruiz-Moreno, Lutz Hamann, Javeed A Shah, et al.
Pageof 28

Showing results (201-210 of 278) with videos related to

Sort By:
Pageof 28
Scientific Reports|November 29, 2022
Transcriptomic comparison of primary human lung cells with lung tissue samples and the human A549 lung cell line highlights cell type specific responses during infections with influenza A virusWilhelm Bertrams, Katja Hönzke, Benedikt Obermayer, et al.
Translational Lung Cancer Research|March 15, 2021
KRAS<sup>G12C</sup>/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinomaNikolaj Frost, Jens Kollmeier, Claudia Vollbrecht, et al.
Infection|July 9, 2023
Pathogen spectrum of community acquired pneumonia in people living with HIV (PLWH) in the German CAPNETZ-CohortBenjamin T Schleenvoigt, Juliane Ankert, Grit Barten-Neiner, et al.
Respiratory Research|September 10, 2022
Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study groupMathias W Pletz, Andreas Vestergaard Jensen, Christina Bahrs, et al.
Mbio|October 10, 2013
The novel human influenza A(H7N9) virus is naturally adapted to efficient growth in human lung tissueJessica Knepper, Kristina L Schierhorn, Anne Becher, et al.
Critical Care (London, England)|November 15, 2017
Vasculotide reduces pulmonary hyperpermeability in experimental pneumococcal pneumoniaBirgitt Gutbier, Xiaohui Jiang, Kristina Dietert, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 17, 2021
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational studyBarbara Mühlemann, Charlotte Thibeault, David Hillus, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 18, 2022
Initial Experience With SARS-CoV-2-Neutralizing Monoclonal Antibodies in Kidney or Combined Kidney-Pancreas Transplant RecipientsFriederike Bachmann, Klemens Budde, Norbert Suttorp, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2015
CFTR and sphingolipids mediate hypoxic pulmonary vasoconstrictionChristoph Tabeling, Hanpo Yu, Liming Wang, et al.
Plos Pathogens|January 4, 2018
The common HAQ STING variant impairs cGAS-dependent antibacterial responses and is associated with susceptibility to Legionnaires' disease in humansJuan S Ruiz-Moreno, Lutz Hamann, Javeed A Shah, et al.
Pageof 28